SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Montag A & Associates Inc.

Montag A & Associates Inc. decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 98.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 600 shares of the exchange traded fund’s stock after selling 40,809 shares during the period. Montag A & Associates Inc.’s holdings in SPDR S&P Biotech ETF were worth $54,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $29,000. Avior Wealth Management LLC boosted its stake in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares during the last quarter. Tidemark LLC grew its position in shares of SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth $40,000. Finally, Howe & Rusling Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth $49,000.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $91.41 on Tuesday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The company has a 50-day moving average of $91.63 and a 200-day moving average of $96.06. The company has a market capitalization of $6.97 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.